PARP3 and glioblastoma: In addition, despite an absence of overt phenotype in the PARP3-knockout glioblastoma cells exemplified by normal proliferation and normal in vivo tumor progression, we provide strong evidence that PARP3 dysfunction participates in enhancing the fragility of cytoskeletal microtubules that confers vulnerability to microtubule-destabilizing agents.